Top Markets
Coin of the day
Alar Pharmaceuticals Inc. Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc.

6785
株式のランク #18601
Alar Pharmaceuticals Inc., a drug development company, focuses on developing... Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
株価
$2.88
時価総額
$192.66M
変化(1日)
-0.55%
変化(1年)
-59.61%
TW
取引 Alar Pharmaceuticals Inc. (6785)

カテゴリー

Alar Pharmaceuticals Inc.(6785)のP/B比率
2026 時点のP/B比率 TTM: 0
Alar Pharmaceuticals Inc. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
Alar Pharmaceuticals Inc. の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。